Comparing the Digestion of Milk With Different Beta-casein Protein Content by Dairy Intolerant Persons

  • STATUS
    Recruiting
  • End date
    Dec 31, 2023
  • participants needed
    200
  • sponsor
    Purdue University
Updated on 24 January 2021

Summary

Persons with dairy intolerance may experience cramps/abdominal pain, bloating, flatulence, acute diarrhea, or fecal urgency when they ingest excessive amounts of lactose. The intensity of these conditions can be mild or severe and likely depends on numerous variables including dose, transit time, intestinal residual lactase activity and microbiome potential to ferment lactose. Jersey cattle produce milk containing high levels of the A2 -casein protein . There are claims that high A2 -casein milk is more easily digested by people who are lactose maldigesters . We propose to conduct a double-blinded, randomized, controlled trial to determine if high A2 -casein milk from Jersey cattle is actually better digested and tolerated by lactose maldigesters.

Description

Persons with dairy intolerance may experience cramps/abdominal pain, bloating, flatulence, acute diarrhea, or fecal urgency when they ingest excessive amounts of lactose. The intensity of these conditions can be mild or severe and likely depends on numerous variables including dose, transit time, intestinal residual lactase activity and microbiome potential to ferment lactose. Jersey cattle produce milk containing high levels of the A2 -casein protein . There are claims that high A2 -casein milk is more easily digested by people who are lactose maldigesters . We propose to conduct a double-blinded, randomized, controlled trial to determine if high A2 -casein milk from Jersey cattle is actually better digested and tolerated by lactose maldigesters.

This proposed protocol comparing the dairy intolerance symptoms from milks containing predominantly the A1 variant versus A2 variant will establish if high A2 milk is better digested and/or tolerated than high A1 milk.

Participants will be asked to consume four different commercially available milks in random order. The samples will be fed for breakfast separated by at least 10 days, after overnight fasts. The commercial milk treatments will include; high A1 -casein milk (commercial milk), high A2 -casein milk, Jersey cattle milk (which contains a mixture of A1 and A2 -casein), and a lactose free milk control. Milk will be 2% fat content to control for transit. Each subject will be fed milk containing 0.5g lactose per kg body weight. There will be two arms in this study: dairy intolerant who are lactose maldigesters, and dairy intolerant who are lactose digesters.

Details
Condition Dairy Intolerance
Treatment Lactose free milk, Jersey milk, High A1 β-casein milk, High A2 β-casein milk
Clinical Study IdentifierNCT03713346
SponsorPurdue University
Last Modified on24 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Ability/desire to provide informed consent
Aged 18 to 65 years of age inclusive at screening
Current or recent history of intolerance to and avoidance of milk of at least one month duration (by self-report and self-reported symptoms)
Agrees to refrain from all other treatments and products used for lactose intolerance (e.g., Lactaid Dietary Supplements) during study involvement
Willing to return for all study visits and complete all study related procedures, including fasting before and during the hydrogen breath tests
Qualifying Lactose Challenge Symptom Score
(4 symptom categories with severity measured on from 0 to 5) as defined by one
of the
following
At least one score of "moderately severe" or "severe" on a single symptom during the 6 hour HBT test
A score of "moderate" or greater for a single symptom on at least two (2) time points during the 6 hour HBT test
At least one "moderate" score or greater on each of two symptoms during the 6 hour HBT test 7. Hydrogen concentration of at least 20 parts per million greater than baseline at least 2 time points during the screening hydrogren breath test 8. Able to understand and provide written informed consent in English

Exclusion Criteria

Allergic to milk
Currently pregnant
Currently lactating
Cigarette smoking or other use of tobacco or nicotine containing products within 3 months of screening
Diagnosed with any of the following disorders known to be associated with abnormal gastrointestinal motility such as; Gastroparesis, amyloidosis, neuromuscular diseases (including Parkinson's disease), collagen vascular diseases, alcoholism, uremia, malnutrition, or untreated hypothyroidism
History of surgery that alters the normal function of the gastrointestinal tract including, but not limited to: gastrointestinal bypass surgery, bariatric surgery, gastric banding, vagotomy, fundoplication, pyloroplasty [Note: history of uncomplicated abdominal surgeries such as removal of an appendix more than 12 months prior to screening will not be excluded]
Past or present : Organ transplant, chronic pancreatitis, pancreatic insufficiency, symptomatic biliary disease, Celiac disease, chronic constipation, diverticulosis, inflammatory bowel disease (IBD), ulcerative colitis (UC), Crohn's disease (CD), small intestine bacterial overgrowth syndrome (SIBO), gastroparesis, gastro-esophageal reflux disease (GERD), Irritable Bowel Syndrome (IBS) or any other medical condition with symptoms that could confound collection of adverse events
Active ulcers, or history of severe ulcers
Diabetes mellitus (type 1 and type 2)
Congestive Heart Failure (CHF)
Human Immunodeficiency Virus (HIV), Hepatitis B or Hepatitis C
BMI > 35 kg/m2
Recent bowel preparation for endoscopic or radiologic investigation within four weeks of screening (e.g., colonoscopy prep)
Use of concurrent therapy(ies) or other products (e.g., laxatives, stool softeners, Pepto Bismol, Lactaid Dietary Supplements) used for symptoms of lactose intolerance within 7 days of screening
Chronic antacid and/or PPI use
Recent use of systemic antibiotics defined as use within 30 days prior to screening
Recent high colonic enema, defined as use within 30 days prior to screening
Any concurrent disease or symptoms which may interfere with the assessment of the cardinal symptoms of lactose intolerance (i.e., gas, diarrhea, bloating, cramps, stomach pain)
History of ethanol (alcohol) and/or drug abuse in the past 12 months
Currently undergoing chemotherapy
Use of any investigational drug or participation in any investigational study within 30 days prior to screening
Prior enrollment in this study
Any other conditions/issues noted by the study staff and/or Principal Investigator that would impact participation and/or protocol compliance
\-
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note